Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
36
GSK Quote, Financials, Valuation and Earnings
Last price:
$48.99
Seasonality move
:
6.89%
Day range:
$48.69 - $49.04
52-week range:
$31.72 - $49.44
Dividend yield:
3.42%
P/E ratio:
13.96x
P/S ratio:
2.40x
P/B ratio:
4.53x
Volume:
1.1M
Avg. volume:
4M
1-year change:
43.87%
Market cap:
$98.4B
Revenue:
$40.1B
EPS (TTM):
$3.51
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $43.7B | $34B | $36.1B | $37.7B | $40.1B | |
| Revenue Growth (YoY) | 1.55% | -22.33% | 6.35% | 4.37% | 6.35% | |
| Cost of Revenues | $14.1B | $11.5B | $12.1B | $11.3B | $12.1B | |
| Gross Profit | $29.7B | $22.5B | $24B | $26.4B | $28B | |
| Gross Profit Margin | 67.81% | 66.18% | 66.37% | 70.07% | 69.8% | |
| R&D Expenses | $5.7B | $6B | $6B | $6.5B | $7B | |
| Selling, General & Admin | $523.2M | $232.4M | $236.5M | $247.4M | $253M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $19.2B | $15B | $15.7B | $17.7B | $20.7B | |
| Operating Income | $10.5B | $7.4B | $8.2B | $8.7B | $7.2B | |
| Net Interest Expenses | $1.1B | $1.1B | $1B | $963.4M | $822.9M | |
| EBT. Incl. Unusual Items | $8.9B | $4.9B | $6.9B | $7.5B | $4.4B | |
| Earnings of Discontinued Ops. | -- | $1.5B | $12.9B | -- | -- | |
| Income Tax Expense | $743.8M | $114.2M | $870.9M | $939.7M | $672.1M | |
| Net Income to Company | $8.2B | $4.8B | $6.1B | $6.6B | $3.8B | |
| Minority Interest in Earnings | $819.4M | $275.1M | $566.6M | $472.4M | $480.5M | |
| Net Income to Common Excl Extra Items | $8.2B | $4.8B | $6.1B | $6.6B | $3.8B | |
| Basic EPS (Cont. Ops) | $3.70 | $3.77 | $9.15 | $3.02 | $1.61 | |
| Diluted EPS (Cont. Ops) | $3.66 | $3.72 | $9.02 | $2.98 | $1.59 | |
| Weighted Average Basic Share | $2B | $1.6B | $2B | $2B | $2B | |
| Weighted Average Diluted Share | $2B | $1.6B | $2B | $2.1B | $2.1B | |
| EBITDA | $13.5B | $10.4B | $10.9B | $11.5B | $10.5B | |
| EBIT | $10.5B | $7.4B | $8.2B | $8.7B | $7.2B | |
| Revenue (Reported) | $43.7B | $34B | $36.1B | $37.7B | $40.1B | |
| Operating Income (Reported) | $10.5B | $7.4B | $8.2B | $8.7B | $7.2B | |
| Operating Income (Adjusted) | $10.5B | $7.4B | $8.2B | $8.7B | $7.2B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.1B | $9.2B | $10.3B | $10.4B | $11.5B | |
| Revenue Growth (YoY) | -18.23% | 0.8% | 12.02% | 1.03% | 10.64% | |
| Cost of Revenues | $2.7B | $2.8B | $2.9B | $3B | $3B | |
| Gross Profit | $6.4B | $6.4B | $7.4B | $7.4B | $8.5B | |
| Gross Profit Margin | 70.27% | 69.19% | 72.22% | 70.94% | 73.8% | |
| R&D Expenses | $1.9B | $1.5B | $1.8B | $1.9B | $2.1B | |
| Selling, General & Admin | $2.3B | $2.4B | $2.9B | $4.9B | $3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $4.2B | $3.9B | $4.6B | $6.8B | $5B | |
| Operating Income | $2.2B | $2.5B | $2.8B | $618.8M | $3.5B | |
| Net Interest Expenses | $268.7M | $235.1M | $230.3M | $202.8M | $225.2M | |
| EBT. Incl. Unusual Items | $1.6B | $1.2B | $2.3B | $84.5M | $3.3B | |
| Earnings of Discontinued Ops. | $401M | $11.8B | -- | -- | -- | |
| Income Tax Expense | $338.9M | $273.9M | $325.2M | -$1.3M | $420.7M | |
| Net Income to Company | $407.2M | $63.3M | $2B | $93.1M | $3B | |
| Minority Interest in Earnings | $95.1M | $23.5M | $88.6M | $159.9M | $176.6M | |
| Net Income to Common Excl Extra Items | $1.3B | $915.8M | $1.9B | $84.5M | $2.9B | |
| Basic EPS (Cont. Ops) | $0.80 | $6.31 | $0.91 | -$0.04 | $1.35 | |
| Diluted EPS (Cont. Ops) | $0.79 | $6.22 | $0.90 | -$0.04 | $1.32 | |
| Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
| Weighted Average Diluted Share | $2B | $2B | $2.1B | $2B | $2.1B | |
| EBITDA | $3.5B | $4B | $3.6B | $1.9B | $4.5B | |
| EBIT | $2.2B | $2.5B | $2.8B | $618.8M | $3.5B | |
| Revenue (Reported) | $9.1B | $9.2B | $10.3B | $10.4B | $11.5B | |
| Operating Income (Reported) | $2.2B | $2.5B | $2.8B | $618.8M | $3.5B | |
| Operating Income (Adjusted) | $2.2B | $2.5B | $2.8B | $618.8M | $3.5B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $39.1B | $37.1B | $36.4B | $39.7B | $42.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $12.4B | $12.9B | $10.2B | $11.6B | $11.6B | |
| Gross Profit | $26.7B | $24.2B | $26.2B | $28B | $30.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $6.9B | $6.4B | $7B | $7B | $8.9B | |
| Selling, General & Admin | $12.2B | $10.4B | $11.2B | $14B | $11.9B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $18.5B | $16.4B | $18B | $20.8B | $20.6B | |
| Operating Income | $8.1B | $7.8B | $8.2B | $7.3B | $9.9B | |
| Net Interest Expenses | $1.1B | $1B | $1B | $908.2M | $896.7M | |
| EBT. Incl. Unusual Items | $6.3B | $5.5B | $9B | $4.2B | $9.2B | |
| Earnings of Discontinued Ops. | $654.1M | $12.8B | -$5.9M | -- | -- | |
| Income Tax Expense | $389.8M | $737.5M | $964.7M | $563.5M | $1.2B | |
| Net Income to Company | $5.5B | $4.7B | $8B | $3.5B | $8.1B | |
| Minority Interest in Earnings | $646.6M | $434.4M | $558M | $429.1M | $745.7M | |
| Net Income to Common Excl Extra Items | $5.9B | $4.8B | $8B | $3.6B | $8B | |
| Basic EPS (Cont. Ops) | $2.97 | $8.67 | $3.68 | $1.55 | $3.56 | |
| Diluted EPS (Cont. Ops) | $2.94 | $8.55 | $3.64 | $1.54 | $3.51 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $11.9B | $11.1B | $10.3B | $11.5B | $14.5B | |
| EBIT | $8.1B | $7.8B | $8.2B | $7.3B | $9.9B | |
| Revenue (Reported) | $39.1B | $37.1B | $36.4B | $39.7B | $42.1B | |
| Operating Income (Reported) | $8.1B | $7.8B | $8.2B | $7.3B | $9.9B | |
| Operating Income (Adjusted) | $8.1B | $7.8B | $8.2B | $7.3B | $9.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $27.5B | $27.5B | $27.7B | $29.7B | $31.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8.5B | $9.1B | $7.6B | $8.1B | $8.3B | |
| Gross Profit | $19.1B | $18.4B | $20.2B | $21.6B | $23.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $5.1B | $4.6B | $5B | $5.4B | $6.5B | |
| Selling, General & Admin | $8B | $7.4B | $8.3B | $10.7B | $8.5B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $12.9B | $11.8B | $13.1B | $16B | $14.9B | |
| Operating Income | $6.2B | $6.6B | $7.1B | $5.6B | $8.4B | |
| Net Interest Expenses | $810.2M | $765.9M | $708.6M | $632.8M | $675M | |
| EBT. Incl. Unusual Items | $5.2B | $5.1B | $7.1B | $3.7B | $8.5B | |
| Earnings of Discontinued Ops. | $654.1M | $12.4B | -- | -- | -- | |
| Income Tax Expense | $413.6M | $895.2M | $963.5M | $587.1M | $1.2B | |
| Net Income to Company | $4.3B | $4.1B | $6.2B | $3.1B | $7.4B | |
| Minority Interest in Earnings | $432.6M | $442.5M | $411.4M | $369.6M | $634.2M | |
| Net Income to Common Excl Extra Items | $4.8B | $4.2B | $6.1B | $3.1B | $7.3B | |
| Basic EPS (Cont. Ops) | $2.52 | $8.04 | $2.81 | $1.34 | $3.30 | |
| Diluted EPS (Cont. Ops) | $2.49 | $7.93 | $2.78 | $1.33 | $3.25 | |
| Weighted Average Basic Share | $6B | $6B | $6.1B | $6.1B | $6.1B | |
| Weighted Average Diluted Share | $6.1B | $6.1B | $6.1B | $6.2B | $6.2B | |
| EBITDA | $8.7B | $9.5B | $9.1B | $8.4B | $12B | |
| EBIT | $6.2B | $6.6B | $7.1B | $5.6B | $8.4B | |
| Revenue (Reported) | $27.5B | $27.5B | $27.7B | $29.7B | $31.7B | |
| Operating Income (Reported) | $6.2B | $6.6B | $7.1B | $5.6B | $8.4B | |
| Operating Income (Adjusted) | $6.2B | $6.6B | $7.1B | $5.6B | $8.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.7B | $5.9B | $9.5B | $6.6B | $4.9B | |
| Short Term Investments | $106.3M | $82.3M | $5B | $2.9B | $26.4M | |
| Accounts Receivable, Net | $7.6B | $8.5B | $6.6B | $7.5B | $7B | |
| Inventory | $8.2B | $7.8B | $6.2B | $7B | $7.1B | |
| Prepaid Expenses | $490.7M | $426.7M | $412.6M | $452.6M | $488.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $27.7B | $25.3B | $25B | $23.8B | $21.3B | |
| Property Plant And Equipment | $15B | $14.5B | $11.6B | $12.7B | $12.6B | |
| Long-Term Investments | $4.8B | $4.3B | $3B | $2.7B | $2.8B | |
| Goodwill | $14.4B | $14.2B | $8.5B | $8.7B | $8.8B | |
| Other Intangibles | $40.6B | $40.6B | $17.3B | $18.8B | $19.5B | |
| Other Long-Term Assets | -- | -- | -- | -- | $2.4B | |
| Total Assets | $109.9B | $107.1B | $72.3B | $75.2B | $74.5B | |
| Accounts Payable | $6B | $6.1B | $4.7B | $4.7B | $4.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $313.5M | $274M | $202.1M | $198.7M | $210.8M | |
| Other Current Liabilities | $1B | $1.3B | $1.6B | $1.3B | $1.5B | |
| Total Current Liabilities | $30.3B | $32.1B | $27.4B | $26.9B | $27.2B | |
| Long-Term Debt | $32B | $27.9B | $20.5B | $19.4B | $18.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $81.5B | $78.2B | $60.2B | $58.9B | $58.1B | |
| Common Stock | $1.8B | $1.8B | $1.6B | $1.7B | $1.7B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $19.9B | $20.4B | $12.7B | $17B | $17.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.5B | $8.5B | -$603.9M | -$703.7M | -$732.7M | |
| Total Equity | $28.4B | $28.9B | $12.1B | $16.3B | $16.4B | |
| Total Liabilities and Equity | $109.9B | $107.1B | $72.3B | $75.2B | $74.5B | |
| Cash and Short Terms | $8.7B | $5.9B | $9.5B | $6.6B | $4.9B | |
| Total Debt | $37.1B | $31.7B | $23.3B | $21.7B | $20.3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.7B | $8B | $8.2B | $4.3B | $4.5B | |
| Short Term Investments | $81.9M | $4B | $4.3B | $26.8M | -- | |
| Accounts Receivable, Net | $10.4B | $8.4B | $10.4B | $9.9B | $10.7B | |
| Inventory | $8.4B | $5.2B | $6.7B | $7.9B | $8.2B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $24.6B | $22.6B | $25.9B | $23.2B | $24B | |
| Property Plant And Equipment | $14.4B | $10.8B | $11.5B | $13B | $13.6B | |
| Long-Term Investments | $3.8B | $1.8B | $1.4B | $1.5B | $1.5B | |
| Goodwill | $14.2B | $8B | $8.5B | $8.9B | -- | |
| Other Intangibles | $40.6B | $17.4B | $18.7B | $20.1B | -- | |
| Other Long-Term Assets | $1.7B | $1.3B | $1.4B | $2.6B | -- | |
| Total Assets | $106.1B | $67.3B | $74.3B | $77.9B | $82.6B | |
| Accounts Payable | $20.5B | $18B | $19B | $19.3B | $21.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1B | $1.1B | $1.2B | $1.5B | -- | |
| Total Current Liabilities | $30.2B | $23.4B | $27.3B | $28.8B | $28.7B | |
| Long-Term Debt | $28B | $21.6B | $19.5B | $17.8B | $20.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $76.8B | $57.6B | $58.9B | $59.8B | $61.4B | |
| Common Stock | $1.8B | $1.5B | $1.6B | $1.8B | $1.8B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $8.5B | -$486.7M | -$627.4M | -$744.4M | -$533.1M | |
| Total Equity | $29.3B | $9.7B | $15.4B | $18B | $21.2B | |
| Total Liabilities and Equity | $106.1B | $67.3B | $74.3B | $77.9B | $82.6B | |
| Cash and Short Terms | $4.7B | $8B | $8.2B | $4.3B | $4.5B | |
| Total Debt | $34.5B | $21.6B | $19.5B | $17.8B | $20.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.2B | $4.8B | $6.1B | $6.6B | $3.8B | |
| Depreciation & Amoritzation | $3B | $2.9B | $2.6B | $2.9B | $3.3B | |
| Stock-Based Compensation | $488.6M | $471.7M | $426.2M | $381.6M | $439.6M | |
| Change in Accounts Receivable | -$491.1M | -$1.6B | -$758.8M | -$806.7M | $434.5M | |
| Change in Inventories | $152.6M | $70.1M | -$331.3M | -$527.1M | -$375.7M | |
| Cash From Operations | $9.8B | $9.9B | $8.2B | $7.9B | $7.8B | |
| Capital Expenditures | $2.9B | $3.7B | $2.8B | $2.9B | $3.8B | |
| Cash Acquisitions | $153.9M | $180.2M | $4B | $1.8B | $1.1B | |
| Cash From Investing | $2.7B | -$2.5B | -$10.9B | -$2.4B | -$1.8B | |
| Dividends Paid (Ex Special Dividend) | $5.1B | $5.5B | $4.3B | $2.8B | $3.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.2B | $414.1M | $2.5B | $277.5M | $1.7B | |
| Long-Term Debt Repaid | -$9.4B | -$3.2B | -$8.3B | -$3.2B | -$3.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$866.3M | -$572.3M | $13B | $424.3M | $176.4M | |
| Cash From Financing | -$11.9B | -$9.4B | $2B | -$6.1B | -$5.2B | |
| Beginning Cash (CF) | $8.6B | $5.8B | $4.5B | $3.7B | $4.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $552.7M | -$2B | -$485.3M | -$704.8M | $696.4M | |
| Ending Cash (CF) | $9.1B | $3.8B | $4.2B | $2.9B | $5.5B | |
| Levered Free Cash Flow | $6.9B | $6.3B | $5.4B | $5B | $4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $407.2M | $63.3M | $2B | $93.1M | $3B | |
| Depreciation & Amoritzation | $1.3B | $1.1B | $744.6M | $1.2B | $1B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.5B | $1.5B | $2.8B | $2.7B | $3B | |
| Capital Expenditures | $1.7B | $561.3M | $641.3M | $1.1B | $1.2B | |
| Cash Acquisitions | $47.1M | $3.8B | $107.7M | $7.2M | $1.2B | |
| Cash From Investing | -$1.6B | -$5B | -$669.7M | -$952.6M | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | $1.3B | $799.5M | $729.9M | $781.6M | $905.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $956.8M | -$746M | -- | -- | |
| Long-Term Debt Repaid | -$303.5M | -$2.1B | -$554.9M | -$747.2M | -- | |
| Repurchase of Common Stock | -- | -$3.9M | -- | -- | $448M | |
| Other Financing Activities | -$91.4M | $252.1M | -$7.3M | $132.1M | -- | |
| Cash From Financing | -$1.9B | -$1.7B | -$2.2B | -$1.5B | -$1.7B | |
| Beginning Cash (CF) | $4.7B | $4B | $3.9B | $4.3B | $4.4B | |
| Foreign Exchange Rate Adjustment | $18.2M | $25.5M | $27.3M | -$43.2M | $77M | |
| Additions / Reductions | $2.4M | -$5.3B | -$29.1M | $189.1M | -$752.2M | |
| Ending Cash (CF) | $4.7B | -$1.2B | $3.9B | $4.4B | $3.8B | |
| Levered Free Cash Flow | $1.8B | $889.1M | $2.1B | $1.7B | $1.8B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.5B | $4.7B | $8B | $3.5B | $8.1B | |
| Depreciation & Amoritzation | $6B | $3.3B | $2B | $4.1B | $4.7B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $9.8B | $11B | $6B | $8.6B | $9.8B | |
| Capital Expenditures | $4B | $2.6B | $2.8B | $3.3B | $4.1B | |
| Cash Acquisitions | $189.5M | $4B | $1.9B | $942.9M | $2.4B | |
| Cash From Investing | -$2B | -$10.9B | -$3.1B | $9.4M | -$6.1B | |
| Dividends Paid (Ex Special Dividend) | $5.5B | $4.8B | $2.8B | $3B | $3.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -$1.8B | -- | |
| Long-Term Debt Repaid | -$2.7B | -$8.3B | -$3.9B | -$3.5B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $1.5B | |
| Other Financing Activities | -$1.7B | $12B | $1.2B | $428.1M | -- | |
| Cash From Financing | -$8.6B | $14.1M | -$3.3B | -$8.5B | -$4.1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$844.1M | $303.6M | -$401.7M | $22M | -$366.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $5.8B | $8.4B | $3.2B | $5.4B | $5.6B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.3B | $4.1B | $6.2B | $3.1B | $7.4B | |
| Depreciation & Amoritzation | $2.5B | $2.9B | $2.1B | $2.7B | $3.6B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.2B | $6.3B | $4.2B | $5B | $6.9B | |
| Capital Expenditures | $2.9B | $1.9B | $2B | $2.3B | $2.6B | |
| Cash Acquisitions | $150.1M | $3.9B | $1.8B | $965.1M | $2.2B | |
| Cash From Investing | -$2B | -$10.4B | -$2.7B | -$282.8M | -$4.6B | |
| Dividends Paid (Ex Special Dividend) | $4.2B | $3.5B | $2.1B | $2.3B | $2.5B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $956.8M | $2.1B | -- | $3.6B | |
| Long-Term Debt Repaid | -$798.3M | -$5.9B | -$1.6B | -$1.8B | -$2.2B | |
| Repurchase of Common Stock | -- | -$100 | -- | -- | $1.5B | |
| Other Financing Activities | -$570.8M | $12B | $231.7M | $235.5M | $158.9M | |
| Cash From Financing | -$6B | $3.3B | -$2B | -$4.4B | -$3.2B | |
| Beginning Cash (CF) | $16.1B | $16.8B | $11.4B | $11.6B | $15.1B | |
| Foreign Exchange Rate Adjustment | -$29.2M | $133.4M | -$81.5M | -$77.4M | $29.2M | |
| Additions / Reductions | -$2.9B | -$587.6M | -$507.9M | $215.6M | -$854.3M | |
| Ending Cash (CF) | $13.2B | $16.3B | $10.9B | $11.7B | $14.3B | |
| Levered Free Cash Flow | $2.3B | $4.4B | $2.3B | $2.7B | $4.3B | |
Get GSK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GSK
Sector
P/E ratio
13.96x
23.89x
PEG ratio
0.11x
-0.01x
P/B ratio
4.53x
1.81x
Price / LTM sales
2.40x
1.59x
Growth Metrics
GSK
Sector
Revenue growth
10.64%
4.62%
Earnings growth
3676.49%
11.06%
Revenue (5-year growth)
-1.42%
6.5%
Earnings forecast
$1.26
-$0.21
Profitability
GSK
Sector
Profitability FY 2024
$28B
$3.6M
Return on invested capital
19.21%
-31.84%
Return on assets
10.09%
-27.96%
Return on equity
42.84%
-37.63%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Jan
28
Balance Sheet
GSK
Sector
Total cash
$4.5B
$26.4M
Short term investments
$26.4M
$25.7M
Total assets
$74.5B
$76.9M
Long term debt
$20.1B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
